Published in Blood Weekly, December 7th, 2000
This new recombinant Factor VIII excludes any added proteins or raw materials derived from human or animal sources in the manufacture, purification, and formulation of the final product. The product is, thereby, designed to virtually eliminate the theoretical risk of transmission of infectious agents potentially associated with products which contain human or animal-derived additives. Factor VIII, or antihemophilic factor, is the protein in human blood that is critical for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.